News
Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership Mechelen, Belgium; June 23, 2025, 07:30 CET; regulated ...
The cystinosis treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough th ...
Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...
Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership Mechelen, Belgium; June 23, 2025, 07:30 CET; regulated ...
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
The Making of a Heart Attack features renowned former football running back, Barry Sanders, who reveals he experienced a ...
Medicus Pharma (NASDAQ: MDCX) remains in the spotlight as Wall Street analysts reaffirm a bullish outlook, maintaining a ...
NervGen Pharma targets a neglected market with significant unmet needs, offering high-risk, high-reward potential if NVG-291 ...
Amid this estimated $100 billion opportunity, much smaller upstart Viking Therapeutics (VKTX-0.88%) has emerged with a promising clinical pipeline, aiming to capture a share of the weight loss and ...
2d
Medpage Today on MSNIBD Biomarkers: Established Tests Are Helpful but Clinicians Want MoreTwo biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results